Lotus Bio-Technology Development Corp. engages in improving healthcare and advancing diagnostics through technology development and market acquisition. The company is headquartered in Costa Mesa, California. The company went IPO on 2013-03-14. The firm delivers a series of at-home diagnostic tests that help form a complete picture of their current overall health including hormone levels, allergies, sensitivities, and any pre-existing conditions or infections. Then, based on those results, and a user's interests, lifestyle and goals, an advisor from The Company works with the individual one on one to help customize a wellness plan that incentivizes them to continue caring for their health and reach new goals. Through the Company's at-home diagnostic testing, customizable wellness plans, and strategic partnerships, the Company provides access to healthcare and improve quality of life for its users.
Follow-Up Questions
¿Quién es el CEO de Lotus Bio-Technology Development Corp?
Mr. Zoltan Nagy es el President de Lotus Bio-Technology Development Corp, se unió a la empresa desde 2011.
¿Qué tal es el rendimiento del precio de la acción LBTD?
El precio actual de LBTD es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Lotus Bio-Technology Development Corp?
Lotus Bio-Technology Development Corp pertenece a la industria N/A y el sector es N/A
¿Cuál es la capitalización bursátil de Lotus Bio-Technology Development Corp?
La capitalización bursátil actual de Lotus Bio-Technology Development Corp es $0
